Activation of JAK2/STAT pathway in cerebral cortex after experimental traumatic brain injury of rats

Neuroscience Letters

Volumn 498, Issue 2, 2011, Pages 147-152

  Zhao, Jin bing ^a   Zhang, Yang ^a   Li, Guang zhao ^b   Su, Xing fen ^a   Hang, Chun hua ^a,b  

^a NANJING UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

AG490; JAK2; Neurological Severity Scores; STAT1; STAT3; Traumatic brain injury

Indexed keywords

JANUS KINASE 2; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; STAT1 PROTEIN; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; BRAIN CORTEX; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; GEL MOBILITY SHIFT ASSAY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING;

ANIMALS; ASTROCYTES; BRAIN INJURIES; CONTUSIONS; ENZYME ACTIVATION; ENZYME INDUCTION; GENE EXPRESSION REGULATION; JANUS KINASE 2; MALE; NEURONS; PARIETAL LOBE; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS; TYRPHOSTINS;

EID: 79958754195     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.05.001     Document Type: Article

References (26)

1. Battle T.E., Frank D.A. The role of STATs in apoptosis. Curr. Mol. Med. 2002, 2:381-392.
2. Bolli R., Dawn B., Xuan Y.T. Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury. Trends Cardiovasc. Med. 2003, 13:72-79.
3. Cattaneo E., Conti L., De-Fraja C. Signalling through the JAK-STAT pathway in the developing brain. Trends Neurosci. 1999, 22:365-369.
4. Chen G., Wu J., Sun C., Qi M., Hang C., Gong Y., Han X., Shi J. Potential role of JAK2 in cerebral vasospasm after experimental subarachnoid hemorrhage. Brain Res. 2008, 1214:136-144.
5. Chen J., Li Y., Wang L., Zhang Z., Lu D., Lu M., Chopp M. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 2001, 32:1005-1011.
6. Chin Y.E., Kitagawa M., Kuida K., Flavell R.A., Fu X.Y. Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol. Cell. Biol. 1997, 17:5328-5337.
7. Darnell J.E., Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421.
8. De-Fraja C., Conti L., Magrassi L., Govoni S., Cattaneo E. Members of the JAK/STAT proteins are expressed and regulated during development in the mammalian forebrain. J. Neurosci. Res. 1998, 54:320-330.
9. Feeney D.M., Boyeson M.G., Linn R.T., Murray H.M., Dail W.G. Responses to cortical injury. I. Methodology and local effects of contusions in the rat. Brain Res. 1981, 211:67-77.
10. Gazit A., Osherov N., Posner I., Yaish P., Poradosu E., Gilon C., Levitzki A. Tyrphostins. 2. Heterocyclic and alpha-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases. J. Med. Chem. 1991, 34:1896-1907.
11. Hergenroeder G.W., Moore A.N., McCoy J.P., Samsel L., Ward N.H., Clifton G.L., Dash P.K. Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. J. Neuroinflammation 2010, 7:19.
12. Imada K., Leonard W.J. The Jak-STAT pathway. Mol. Immunol. 2000, 37:1-11.
13. Kumar A., Commane M., Flickinger T.W., Horvath C.M., Stark G.R. Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 1997, 278:1630-1632.
14. Levy D.E., Lee C.K. What does Stat3 do?. J. Clin. Invest. 2002, 109:1143-1148.
15. Linnekin D., Mou S., Deberry C.S., Weiler S.R., Keller J.R., Ruscetti F.W., Longo D.L. Stem cell factor, the JAK-STAT pathway and signal transduction. Leuk. Lymphoma 1997, 27:439-444.
16. Meydan N, Grunberger T., Dadi H., Shahar M., Arpaia E., Lapidot Z., Leeder J.S., Freedman M., Cohen A., Gazit A., Levitzki A., Roifman C.M. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 1996, 379:645-648.
17. Mui A.L. The role of STATs in proliferation, differentiation, and apoptosis. Cell. Mol. Life Sci. 1999, 55:1547-1558.
18. Osuka K, Watanabe Y., Yamauchi K., Nakazawa A., Usuda N., Tokuda M., Yoshida J. Activation of the JAK-STAT signaling pathway in the rat basilar artery after subarachnoid hemorrhage. Brain Res. 2006, 1072:1-7.
19. Satriotomo I., Bowen K.K., Vemuganti R. JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia. J. Neurochem. 2006, 98:1353-1368.
20. Schindler C., Plumlee C. Inteferons pen the JAK-STAT pathway. Semin. Cell Dev. Biol. 2008, 19:311-318.
21. Suzuki S., Tanaka K., Nogawa S., Dembo T., Kosakai A., Fukuuchi Y. Phosphorylation of signal transducer and activator of transcription-3 (Stat3) after focal cerebral ischemia in rats. Exp. Neurol. 2001, 170:63-71.
22. Thompson J.E. JAK protein kinase inhibitors. Drug News Perspect. 2005, 18:305-310.
23. Wang Y., Wu T.R., Cai S., Welte T., Chin Y.E. Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation. Mol. Cell. Biol. 2000, 20:4505-4512.
24. Xu X., Fu X.Y., Plate J., Chong A.S. IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res. 1998, 58:2832-2837.
25. Yamauchi K., Osuka K., Takayasu M., Usuda N., Nakazawa A., Nakahara N., Yoshida M., Aoshima C., Hara M., Yoshida J. Activation of JAK/STAT signalling in neurons following spinal cord injury in mice. J. Neurochem. 2006, 96:1060-1070.
26. Ziebell J.M., Morganti-Kossmann M.C. Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 2010, 7:22-30.